The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125282582 12528258 2 F 20160530 20160802 20160705 20160810 EXP FR-PFIZER INC-2016324107 PFIZER 46.00 YR M Y 55.00000 KG 20160810 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125282582 12528258 1 PS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) 125 MG (75 MG/M2), CYCLIC AT DAY 1 Y 202356 125 MG
125282582 12528258 2 I EMEND APREPITANT 1 Oral 125 MG, CYCLIC, ON DAY 1 0 125 MG
125282582 12528258 3 I EMEND APREPITANT 1 Oral 80 MG, CYCLIC, FROM DAY 2 TO DAY 6 0 80 MG
125282582 12528258 4 C FLUOROURACILE ACCORD FLUOROURACIL 1 Intravenous (not otherwise specified) 1250 MG (750 MG/M2), FROM DAY 2 TO DAY 6 0 1250 MG
125282582 12528258 5 C CISPLATINE ACCORD CISPLATIN 1 Intravenous (not otherwise specified) 125 MG (75 MG/M2), CYCLIC, AT DAY 1 0 125 MG
125282582 12528258 6 C SKENAN MORPHINE SULFATE 1 10 MG, 2X/DAY 0 10 MG BID
125282582 12528258 7 C PARACETAMOL ACETAMINOPHEN 1 1 G 0
125282582 12528258 8 C PREDNISOLONE. PREDNISOLONE 1 80 MG, CYCLIC, FROM DAY 1 TO DAY 6 0 80 MG
125282582 12528258 9 C ONDANSETRON ONDANSETRON 1 8 MG, CYCLIC, TWICE DAILY FROM DAY 1 TO DAY 6 0 8 MG
125282582 12528258 10 C PRIMPERAN METOCLOPRAMIDE HYDROCHLORIDE 1 UNK 0
125282582 12528258 11 C MACROGOL POLYETHYLENE GLYCOLS 1 UNK 0
125282582 12528258 12 C LAROXYL AMITRIPTYLINE 1 UNK 0
125282582 12528258 13 C ESOMEPRAZOLE ESOMEPRAZOLE 1 UNK 0
125282582 12528258 14 C LOVENOX ENOXAPARIN SODIUM 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125282582 12528258 1 Lip and/or oral cavity cancer
125282582 12528258 2 Prophylaxis of nausea and vomiting
125282582 12528258 4 Lip and/or oral cavity cancer
125282582 12528258 5 Lip and/or oral cavity cancer
125282582 12528258 8 Premedication
125282582 12528258 9 Premedication

Outcome of event

Event ID CASEID OUTC COD
125282582 12528258 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125282582 12528258 Diarrhoea
125282582 12528258 Drug interaction
125282582 12528258 Febrile neutropenia
125282582 12528258 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125282582 12528258 1 20160530 20160530 0
125282582 12528258 2 20160530 20160530 0
125282582 12528258 3 20160531 20160604 0
125282582 12528258 4 20160531 20160604 0
125282582 12528258 5 20160530 20160530 0
125282582 12528258 6 201605 0
125282582 12528258 7 201605 0
125282582 12528258 8 20160530 20160604 0
125282582 12528258 9 20160530 20160604 0
125282582 12528258 10 20160601 20160603 0
125282582 12528258 11 20160603 20160604 0
125282582 12528258 12 20160602 20160602 0
125282582 12528258 13 20160530 20160530 0
125282582 12528258 14 20160531 20160531 0